Related Experiment Video

Updated: Sep 27, 2026

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction
03:42

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction

Published on: March 29, 2024

Chronic heart failure as a metabolic disorder

S D Anker1, F O Al-Nasser

  • 1Franz-Volhard-Klinik (Charité Campus Berlin-Buch), Max-Delbrück Centrum, Berlin, Germany.

Heart Failure Monitor
|March 14, 2003
PubMed

Insights

Heart failure involves complex interactions between neurohormonal and metabolic issues, impacting immune function. Understanding these connections, including tumor necrosis factor-alpha (TNF-alpha), is crucial for managing cardiac cachexia and improving patient outcomes.

Area of Science:

  • Cardiology
  • Endocrinology
  • Immunology

Background:

  • Congestive chronic heart failure (CHF) involves complex interactions of hemodynamic, neurohormonal, and metabolic disturbances.
  • Neurohormonal abnormalities are recognized as key drivers of heart failure progression, leading to therapeutic advancements.

Purpose of the Study:

  • To review the interactions between neurohormonal pathways and metabolic problems in CHF.
  • To highlight the role of inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha), in heart failure pathophysiology.

Main Methods:

  • Literature review focusing on neuroendocrine, hormonal, and inflammatory pathways in CHF.
  • Analysis of the interplay between energy metabolism, immune function, and hormonal regulation.

Main Results:

  • Tumor necrosis factor-alpha (TNF-alpha) is identified as a key molecule linking energy metabolism, immune function, and neuroendocrine pathways.
  • Cardiac cachexia, a severe metabolic complication in CHF, currently lacks specific therapies and has a poor prognosis.

Conclusions:

  • Promising therapeutic strategies targeting TNF-alpha or growth factors exist but carry risks and high costs.
  • Future CHF management requires comprehensive assessment beyond cardiac function, including metabolic status, body composition, and hormonal profiles.

More Related Videos

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...